Studies a walking and talking test for early memory and thinking problems
Tests a walk-and-talk mobility test to help spot early dementia in adults.
Plain-language title generated from the registry record
Registry title: Uppsala-Dalarna Dementia and Gait Project
Key facts
- Where
- Falun and Uppsala, SwedenSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 37 and 94 years old?
Source: NCT05893524, who can take part
Where in Sweden
- Dalarna UniversityFalun, SwedenNo longer taking part
- Uppsala UniversityUppsala, SwedenTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Dalarna University
- Trial code
- NCT05893524
- Record updated
- 12 February 2025
- Original description
UDDGait™ is a multidisciplinary research project with the overreaching goal of providing an aid for early identification of cognitive impairment and risk of dementia development, thereby providing a basis for adequate symptom relieving and health promoting interventions.Read full original descriptionShow less
Uppsala-Dalarna Dementia and Gait Project
UDDGait™ is a multidisciplinary research project with the overreaching goal of providing an aid for early identification of cognitive impairment and risk of dementia development, thereby providing a basis for adequate symptom relieving and health promoting interventions.
A new concept is investigated for this purpose: a "dual-task-test", which implies the combination of a well-established mobility test (Timed Up-and-Go, TUG) with a simultaneous verbal task (i.e. TUG dual-task, TUGdt). This type of test has been judged as a potential aid for early identification of dementia disease. More research is needed to further examine the test's validity, reliability and predictive capacity.
The overall aim is to investigate if TUGdt is useful as an aid for prediction of dementia disease. To ensure the results, the aim is also to evaluate the test's measurement properties and to generate normative reference values of healthy control persons.
Inclusion: Patients undergoing memory assessment at at Uppsala University Hospital, Sweden; Patients undergoing memory assessment at at Falu Hospital, Sweden; Cognitively unimpaired individuals with a Mini Mental State Examination (MMSE) score of > 26.
Exclusion: Inability to walk three meters back and forth; Inability to rise from a sitting position; Indoor use of a walking aid; Current or recent hospitalization (within the last 2 weeks); Need of an interpreter to communicate in Swedish.